278 related articles for article (PubMed ID: 33952631)
1. MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions.
Gkountidi AO; Garnier L; Dubrot J; Angelillo J; Harlé G; Brighouse D; Wrobel LJ; Pick R; Scheiermann C; Swartz MA; Hugues S
Cancer Immunol Res; 2021 Jul; 9(7):748-764. PubMed ID: 33952631
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes.
Li CY; Park HJ; Shin J; Baik JE; Mehrara BJ; Kataru RP
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362253
[TBL] [Abstract][Full Text] [Related]
3. The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells.
Santambrogio L; Berendam SJ; Engelhard VH
Front Immunol; 2019; 10():1033. PubMed ID: 31134089
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells.
Macy AM; Herrmann LM; Adams AC; Hastings KT
Curr Opin Immunol; 2023 Aug; 83():102330. PubMed ID: 37130456
[TBL] [Abstract][Full Text] [Related]
5. Lymph Node Stromal Cell-Intrinsic MHC Class II Expression Promotes MHC Class I-Restricted CD8 T Cell Lineage Conversion to Regulatory CD4 T Cells.
Honan AM; Vazquez EN; Chen Z
J Immunol; 2021 Sep; 207(6):1530-1544. PubMed ID: 34408011
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
7. Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells.
Berendam SJ; Koeppel AF; Godfrey NR; Rouhani SJ; Woods AN; Rodriguez AB; Peske JD; Cummings KL; Turner SD; Engelhard VH
Front Immunol; 2019; 10():816. PubMed ID: 31057546
[TBL] [Abstract][Full Text] [Related]
8. Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses.
Kish DD; Gorbachev AV; Fairchild RL
J Leukoc Biol; 2007 Jul; 82(1):85-92. PubMed ID: 17412917
[TBL] [Abstract][Full Text] [Related]
9. Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.
Gerner MY; Mescher MF
J Immunol; 2009 Mar; 182(5):2726-37. PubMed ID: 19234167
[TBL] [Abstract][Full Text] [Related]
10. Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity.
Harlé G; Kowalski C; Dubrot J; Brighouse D; Clavel G; Pick R; Bessis N; Niven J; Scheiermann C; Gannagé M; Hugues S
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33861848
[TBL] [Abstract][Full Text] [Related]
11. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
[TBL] [Abstract][Full Text] [Related]
13. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.
Rouhani SJ; Eccles JD; Riccardi P; Peske JD; Tewalt EF; Cohen JN; Liblau R; Mäkinen T; Engelhard VH
Nat Commun; 2015 Apr; 6():6771. PubMed ID: 25857745
[TBL] [Abstract][Full Text] [Related]
14. CD11c(hi) dendritic cells regulate the re-establishment of vascular quiescence and stabilization after immune stimulation of lymph nodes.
Tzeng TC; Chyou S; Tian S; Webster B; Carpenter AC; Guaiquil VH; Lu TT
J Immunol; 2010 Apr; 184(8):4247-57. PubMed ID: 20231692
[TBL] [Abstract][Full Text] [Related]
15. CD74 supports accumulation and function of regulatory T cells in tumors.
Bonnin E; Rodrigo Riestra M; Marziali F; Mena Osuna R; Denizeau J; Maurin M; Saez JJ; Jouve M; Bonté PE; Richer W; Nevo F; Lemoine S; Girard N; Lefevre M; Borcoman E; Vincent-Salomon A; Baulande S; Moreau HD; Sedlik C; Hivroz C; Lennon-Duménil AM; Tosello Boari J; Piaggio E
Nat Commun; 2024 May; 15(1):3749. PubMed ID: 38702311
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
[TBL] [Abstract][Full Text] [Related]
17. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
18. Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation.
Nörder M; Gutierrez MG; Zicari S; Cervi E; Caruso A; Guzmán CA
FASEB J; 2012 Jul; 26(7):2835-46. PubMed ID: 22459150
[TBL] [Abstract][Full Text] [Related]
19. Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels.
Zhou C; Wei W; Ma J; Yang Y; Liang L; Zhang Y; Wang Z; Chen X; Huang L; Wang W; Wu S
Mol Ther; 2021 Apr; 29(4):1512-1528. PubMed ID: 33388421
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
